Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer
sciencedirect.com/science/article/pii/S030438...Posted Aug 3, 2026, 1:52 PM UTC
10
sciencedirect.com
Loading comments…